NCT01334424

Brief Summary

Gut hypoperfusion - reperfusion injury is an unavoidable event at the end of laparoscopic surgery. It produces oxidative stress (reactive oxygen species). Malondialdehyde have been demonstrated to be a reliable biomarker for the evaluation of oxidative stress in vivo. Propofol (2, 6 - diisopropylphenol), a highly liposoluble anaesthetic, has a potent antioxidant activity against lipid peroxidation in both in vitron and in vivo studies. On the basis of this knowledge, the investigators hypothesized that propofol has preventive effect for gut hypoperfusion - reperfusion induced injury in robot-assisted laparoscopic radical prostatectomy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2009

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2009

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2010

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

February 27, 2011

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2011

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 13, 2011

Completed
Last Updated

April 13, 2011

Status Verified

April 1, 2011

Enrollment Period

1 year

First QC Date

February 27, 2011

Last Update Submit

April 12, 2011

Conditions

Keywords

Robot assisted laparoscopic radical prostatectomyHypoperfusion reperfusion injury,Propofoloxidative stress

Outcome Measures

Primary Outcomes (1)

  • Amount of Malondialdehyde in plasma

    one day

Study Arms (4)

no propofol

PLACEBO COMPARATOR

induction anesthesia with midazolam 0.2 - 0.3 mg/kg

Drug: propofol

propofol induction

EXPERIMENTAL

induction anesthesia with propofol 2 - 2.5 mg/kg

Drug: propofol

propofol maintenance

EXPERIMENTAL

induction anesthesia with midazolam 0.2 - 0.3 mg/kg and maintain anesthesia with propofol 2 mg/kg.h (maintenance dose)

Drug: propofol

propofol induction and maintenance

EXPERIMENTAL

induction anesthesia with propofol 2 - 2.5 mg/ kg and maintain anesthesia with propofol 2 mg/kg.h (maintenance dose)

Drug: propofol

Interventions

2-2.5 mg/kg for induction plus or not plus 2 mg/kg.h for maintenance

no propofolpropofol inductionpropofol induction and maintenancepropofol maintenance

Eligibility Criteria

Age20 Years - 80 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients receiving robot-assisted laparoscopic radical prostatectomy in ASA II-III physical status

You may not qualify if:

  • history of sepsis or shock, clinically relevant cardiopulmonary disease, persistent tobacco abuse, recent antioxidant or vasoconstrictor use

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dept. of Anesthesiology, Chang Gung Memorial Hospital

Taoyuan District, 333, Taiwan

RECRUITING

MeSH Terms

Interventions

Propofol

Intervention Hierarchy (Ancestors)

PhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic Chemicals

Study Officials

  • Chiao-Fen Luo, MD

    Dept. of Anesthesiology, Chang Gung Memorial Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

February 27, 2011

First Posted

April 13, 2011

Study Start

December 1, 2009

Primary Completion

December 1, 2010

Study Completion

April 1, 2011

Last Updated

April 13, 2011

Record last verified: 2011-04

Locations